Posts

Afbeelding
The Observer Legalising cannabis ‘could earn Treasury £3.5bn’ Report suggests change to law would generate revenue and cut costs across justice system Jamie Doward Sat 2 Jun 2018  21.30 BST Last modified on Sun 3 Jun 2018  12.37 BST Shares 3805 Comments 1,116   The Lib Dems and Greens favour a regulated cannabis market, and 47% people in the UK support selling the drug in licensed shops. Photograph: Cris Faga/Rex Introducing a legal cannabis market to the UK could earn the Treasury between £1bn and £3.5bn a year in tax revenues, a new report suggests. Health Poverty Action, an international development organisation, claims that regulating and legalising cannabis in the UK is an “idea whose time has come” and that the windfall could be used to plug the gap in the NHS budget. “Prohibition has failed,” said the group’s advocacy officer, Natasha Horsfield. “From our perspective, it’s about regulating the market to improve publi

Banned from Wall Street, US cannabis companies go north

Afbeelding
MedMen, a Los Angeles-based chain of marijuana dispensaries, can't trade on Wall Street because cannabis is illegal in its home country. So it listed in Canada. MedMen started trading this week on the Canadian Securities Exchange, or CSE. They're not alone. US cannabis companies are heading north to list on stock exchanges in Canada, where there's no federal ban on marijuana sales. Medical marijuana is legal there, and the country is in the process of legalizing recreational marijuana, too. It's a two-way street. Some Canadian cannabis companies have come south to list on Wall Street exchanges, because they're not subject to the same restrictions that keep US pot growers away. In the US, medical marijuana is legal in 30 states, and recreational is legal in 10. But US cannabis companies can't list on US stock exchanges or even get basic financial services, because marijuana is prohibited by the federal government. "There are no straight roads an